You are here

P&T News

October 17

Progressive scarring of lungs leaves patients short of breath
British research focused on the role of enzymes in bacteria
Top-line results released in NIH-funded comparison of effectiveness
Studies will prepare vaccine candidate for clinical trials

October 16

New data support efficacy of chimeric antigen receptor therapy
Longer period might be needed to prevent virus spread, expert says
Medications and nonpharmacologic recommendations graded

October 15

Replaceable device allows urination without catheterization
Novel antipsychotic and improved rescue therapy take center stage by 2023
Additional exposures were expected, agency says

October 14

Modified sulfonylurea stimulates insulin release
Drug’s effect on weight change, sexual function similar to that of placebo
Approval decision expected in April 2015
Soliris takes the prize at nearly $537,000 per year

October 13

Drug’s effect on weight change, sexual function similar to that of placebo

October 13

Health care worker is first to develop disease in U.S.
Harvard discovery could help prevent clotting and infections
Certain patients with genotype-1 infections need just 8 weeks of treatment
Living-cell bioformulation fails to provide significant improvement

October 12

Harvard discovery could help prevent clotting and infections
Living-cell bioformulation fails to provide significant improvement
Health care worker is first to develop disease in U.S.

October 10

Author identifies financial constraints on antibiotic research
Array of genetic defects thwart targeted treatments

October 8

Oral nucleotide analog demonstrates antiviral activity
Symptoms and severity of the illness are frightening, expert admits

October 7

Switching of currently treated patients is likely to be limited
Dopamine antagonist reduces post-op nausea & vomiting
Authors find over-use of broad-spectrum agents
Potential treatment covers all five viral species

October 6

Method could serve as biomarker in early diagnosis, authors say
Authors look at ethnically and linguistically diverse populations
Implanted ‘counterpulsation’ device squeezes blood through the aorta

Pages

P&T TV

Costly biologics have plan sponsors looking at benefit designs

F. Randy Vogenberg, PhD, RPh: Given the high costs of specialty drugs, sponsors of health plans (especially self-funded ones) are gathering information on costs, benefits, and outcomes to determine what kinds of coverage to offer.

March 2014 interview

Meetings

Nashville, TN
November 3 to November 4
Brussels, Belgium
November 12 to November 14

Free App

MediMedia App IconManaged Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."

Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.